Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Other Non-Current Liabilities (2017 - 2026)

Minerva Neurosciences filings provide 1 years of Other Non-Current Liabilities readings, the most recent being $66.3 million for Q4 2021.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $66.3 million in Q4 2021 year-over-year; TTM through Dec 2021 was $66.3 million, a N/A change, with the full-year FY2021 number at $66.3 million, changed N/A from a year prior.
  • Other Non-Current Liabilities hit $66.3 million in Q4 2021 for Minerva Neurosciences, up from $64.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $66.3 million in Q4 2021 to a low of $61.3 million in Q1 2021.